alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit No.
32.1


Form
10-Q


HPC
Acquisitions, Inc.


File No.
0-53248








Certification
Pursuant to 18 U.S.C. Section 1350, as Adopted


Pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002





In
connection with the Quarterly Report of HPC Acquisitions, Inc. (the “Company”)
on Form 10-Q for the period ending March 31, 2009 as filed with the Securities
and Exchange Commission on the date hereof (the “Report”), I, Craig S. Laughlin,
Chief Executive and Chief Financial Officer of the Company, certify pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:




(1)
            the
      Report fully complies with the requirements of Section 13(a) or 15(d) of
      the Securities Exchange Act of 1934;
and


(2)
            the
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.








Date:
      May 6, 2009
                  By:
                  /s/
      Craig S. LaughlinCraig
      S. LaughlinChief
      Executive Officerand
      Chief Financial Officer




A signed
original of this written statement required by Section 906 has been provided to
HPC Acquisitions, Inc. and will be retained by HPC Acquisitions, Inc. and
furnished to the Securities and Exchange Commission or its staff upon
request.
Exhibit 12.1

                                 KINETEK, INC.
            COMPUTATIONS OF THE RATIOS OF EARNINGS TO FIXED CHARGES
            -------------------------------------------------------
                            (dollars in thousands)


                                                 Year Ended December 31,
                                          -------------------------------------
                                             2005        2004        2003
                                             ----        ----        ----

Fixed Charges
     Interest expense                      $35,739      $35,592     $34,876
     Rental expense included
     in fixed charges                        1,121        1,091       1,004
                                          ---------    ---------   ---------
        Total fixed charges                 36,860       36,683      35,880


Earnings
     Pre-tax income (loss)from
     continuing operations                   3,852         (889)     (4,820)
     Plus:  fixed charges                   36,860       36,683      35,880
                                          ---------    ---------   ---------
        Total Earnings                     $40,712      $35,794     $31,060


Ratio of earnings to fixed charges            1.1          1.0         0.9
                                              ===          ===         ===
[Federal Register Volume 75, Number 83 (Friday, April 30, 2010)]
[Notices]
[Page 22818]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-10145]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Center for 
Scientific Review Special Emphasis Panel, May 26, 2010, 11 a.m. to May 
26, 2010, 2 p.m., National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 which was published in the Federal Register on April 
21, 2010, 75 FR 20852-20853.
    The meeting title has been changed to ``Meeting Conflict: Cancer 
Biomarker.'' The meeting is closed to the public.

    Dated: April 28, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-10145 Filed 4-29-10; 8:45 am]
BILLING CODE 4140-01-P
<PAGE>

Exhibit 21.1

                                  SUBSIDIARIES

- Atrium Door and Window Company - West Coast

- Atrium Door and Window Company of the Northeast

- Atrium Door and Window Company of New York

- Atrium Door and Window Company of Arizona

- Atrium Door and Window Company of New England

- Door Holdings, Inc.

- R.G. Darby Company, Inc

- Total Trim, Inc.

- Wing Industries Holdings, Inc.

- Wing Industries, Inc.

- R.G. Darby Company - South

- Total Trim, Inc. - South

- Heat, Inc.

- H.I.G. Vinyl, Inc.

- Champagne Industries, Inc.

- Thermal Industries, Inc.

- Best Built, Inc.
EXHIBIT 32

       CERTIFICATION OF CHIEF EXECTIVE OFFICER AND CHIEF FINANCIAL OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Massey Exploration Corp. (the
"Company") on Form 10-Q for the period ending May 31, 2011 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Michael
Hawitt, Chief Executive Officer and Chief Financial Officer of the Company,
certify, pursuant to 18 U.S.C. ss.1350, as adopted pursuant to ss.906 of the
Sarbanes-Oxley Act of 2002, that:

     (1)  The Report fully complies with the requirements of section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The information contained in the Report fairly presents, in all
          material respects, the financial condition and result of operations of
          the Company.

IN WITNESS WHEREOF, the undersigned has executed this certification as of the
14th day of July, 2011.


/s/ Michael Hawitt
-----------------------------------
Michael Hawitt
Chief Executive Officer and
Chief Financial Officer
EXHIBIT 23.1




                         Consent of Independent Auditors


We consent to the incorporation by reference in the Registration Statement (Form
S-8 No. 333-54164) of our report dated January 17, 2003, with respect to the
consolidated financial statements of Vascular Solutions, Inc. included in the
Annual Report (Form 10-K) for the year ended December 31, 2002.

Our audits also included the financial statement schedule of Vascular Solutions,
Inc. listed in Item 15(a). This schedule is the responsibility of the Company's
management. Our responsibility is to express an opinion based on our audits. In
our opinion, the financial statement schedule referred to above, when considered
in relation to the basic financial statements taken as a whole, presents fairly
in all material respects the information set forth therein.


                                                      Ernst & Young LLP

Minneapolis, Minnesota
February 26, 2003
I 

115TH CONGRESS 

2D SESSION H. R. 6041 

To designate a mountain ridge in the State of Montana as ‘‘B–47 Ridge’’. 

IN THE HOUSE OF REPRESENTATIVES 

JUNE 7, 2018 

Mr. GIANFORTE introduced the following bill; which was referred to the 

Committee on Natural Resources 

A BILL 

To designate a mountain ridge in the State of Montana 

as ‘‘B–47 Ridge’’. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘B–47 Ridge Designa5 tion Act’’. 

6 SEC. 2. DESIGNATION OF B–47 RIDGE, MONTANA. 

7 (a) DESIGNATION.— 

8 (1) IN GENERAL.—The unnamed mountain 

9 ridge located at 45°14′40.89′′N, 110°43′38.75′′W 

10 that runs south and west of Emigrant Peak in the 

11 Absaroka Range in the State of Montana, which is 


amozie on DSK3GDR082PROD with BILLS
2 

•HR 6041 IH

1 the approximate site of a crash of a B–47, shall be 

2 known and designated as ‘‘B–47 Ridge’’. 

3 (2) REFERENCES.—Any reference in a law, 

4 map, regulation, document, paper, or other record of 

5 the United States to the ridge described in para6 graph (1) shall be deemed to be a reference to ‘‘B– 

7 47 Ridge’’. 

8 (b) AUTHORIZATION FOR PLAQUE.— 

9 (1) IN GENERAL.—A plaque that memorializes 

10 the crash of the B–47 (including denoting the names 

11 of the victims of the crash) may be installed on B– 

12 47 Ridge. 

13 (2) FUNDING.—No Federal funds may be used 

14 to design, procure, install, or maintain the plaque 

15 authorized under paragraph (1). 

Æ 


amozie on DSK3GDR082PROD with BILLS
**EXHIBIT
      31.1**




Certifications





I,
      Chen,
      Quan Long, Chief Executive Officer certify that:





1.
      I have
      reviewed this annual report on Form 10-KSB of China Fruits Corp.





2.
      Based
      on my knowledge, the report does not contain any untrue statement of a material
      fact or omit to state a material fact necessary to make the statements made,
      in
      light of the circumstances under which such statements were made, not misleading
      with respect to the period covered by this annual report;





3.
      Based
      on my knowledge, the financial statements, and other financial information
      included in this annual report, fairly present in all material respects our
      financial condition, results of operations and cash flows as of, and for, the
      periods presented in this annual report;





4.
      Our
      other certifying officers and I am responsible for establishing and maintaining
      disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(c)
      and 15d-(e)) for us and have:





a) Designed
      such disclosure controls and procedures, or caused such disclosure controls
      and
      procedures to be designed under our supervision, to ensure that material
      information relating to us, including its consolidates subsidiaries, is made
      known to us by others within those entities, particularly during the period
      in
      which this report is being prepared;





b) Evaluated
      the effectiveness of our disclosure controls and procedures, and presented
      in
      this report our conclusions about the effectiveness of the disclosure controls
      and procedures, as of the end of the period covered by this report based on
      such
      evaluation; and





c) Disclosed
      in this report any change in our internal control over financial reporting
      that
      occurred during our most recent fiscal period that has materially affected,
      or
      is reasonably likely to materially affect, our internal control over financial
      reporting; and





5.
      Our
      other certifying officers and I have disclosed, based on our most recent
      evaluation, to our auditors and the audit committee of our board of directors
      (or persons performing the equivalent functions):





a)
      all
      significant deficiencies in the design or operation of internal controls which
      could adversely affect our ability to record, process, summarize and report
      financial data and have identified for our auditors any material weaknesses
      in
      internal controls (all of which do not apply); and





b)
      any
      fraud, whether or not material, that involves management or other employees
      who
      have a significant role in our internal controls, (all of which do not apply);
      and








Date:
      April 13, 2007











/s/
      Chen, Quan Long


Chen,
      Quan Long
Presidential Documents

6567 

Federal Register 

Vol. 73, No. 23 

Monday, February 4, 2008 

Title 3— 

The President 

Presidential Determination No. 2008–8 of January 22, 2008 

Determination on the Proposed Agreement for Cooperation 

Between the United States of America and the Republic of 

Turkey Concerning Peaceful Uses of Nuclear Energy 

Memorandum for the Secretary of State [and] the Secretary of Energy 

I have considered the proposed Agreement for Cooperation Between the 

United States of America and the Republic of Turkey Concerning Peaceful 

Uses of Nuclear Energy, signed at Ankara on July 26, 2000, along with 

the views, recommendations, and statements of interested agencies. 

I approve the proposed Agreement and have determined the performance 

of the Agreement will promote, and will not constitute an unreasonable 

risk to, the common defense and security. 

The Secretary of State is authorized to publish this determination in the 

Federal Register. 

THE WHITE HOUSE, 

Washington, January 22, 2008. 

[FR Doc. 08–494 

Filed 2–1–08; 8:58 am] 

Billing code 4710–10–P 


ebenthall on PRODPC61 with MISCELLANEOUSGWBOLD.EPS</GPH>
##### 



Exhibit 23.1

Accountants Consent

Board of Directors
International Aircraft Investors:

We consent to incorporation by reference in the registration statements (No.
333-46411 and 333-46413) on Form S-8 of International Aircraft Investors and
subsidiaries of our report dated January 18, 2002, except as to
notes 5, 6 and
10 to the consolidated financial statements which are as of March 26, 2002 relating to the
consolidated balance sheets of International Aircraft Investors and
subsidiaries as of December 31, 2001 and 2000 and the related consolidated
statements of operations, shareholders equity, and cash flows for each of the
years in the three-year period ended December 31, 2001, which report appears in
the 2001 report on Form 10-K of International Aircraft Investors and
subsidiaries.

KPMG LLP

Los Angeles, California
March 29, 2002

48
EXHIBIT 21  -  SUBSIDIARIES OF THE REGISTRANT MONARCH AVALON, INC.

                                                          Percent
                                 Jurisdiction            of Voting
                                   in Which              Securities
NAME OF CORPORATION              Incorporated              Owned
---------------------------------------------------------------------

Girls' Life, Inc.                  Maryland                 100%

Creampuffs, Inc.                   Maryland                 100%

Broken Windows, Inc.               Maryland                 100%
Exhibit 32.1



CERTIFICATION PURSUANT TO
18 U.S.C. Section 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Cyber Supply Inc.(the "Company") on Form 10-Q for the period ended August 31, 2008 as filed with the Securities and Exchange Commission on the date here of (the "report"), I, Maria Shostak, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) 	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) 	The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated this 15thday of October, 2008.



| | MARIA SHOSTAK                                      
| | ---------------------------------------------------
| | Maria Shostak,                                     
| | Chief Executive Officer and Chief Financial Officer







---
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Federal Trade Commission

# AGENCY:

Federal Trade Commission.

# Time and Date:

2 p.m., Tuesday, April 1, 2008. 

# Place:

Federal Trade Commission Building, Room 532, 600 Pennsylvania Avenue, NW., Washington, DC 20580.

# Status:

Part of this meeting will be open to the public. The rest of the meeting will be closed to the public. 

# Matters to be Considered:

*Portion Open to Public:*                         (1) Oral Argument in REALCOMP II, LTD., Docket 9320.                     

*Portion Closed to the Public:*                         (2) Executive Session to follow Oral Argument in REALCOMP II, LTD., Docket 9320.                     

*Contact Person for More Information:*                         Mitch Katz.                     

*Office of Public Affairs:*                         (202) 326-2180.                    

*Recorded Message:*                         (202) 326-2711.                    

Donald S. Clark,

Secretary.

[FR Doc. 08-955  Filed 2-29-08; 2:06 pm]

BILLING CODE 6750-07-M
EXHIBIT
32.2





Certification
pursuant to 18 U.S.C. Section 1350,


as
adopted pursuant to Section 906 of the Sarbanes-Oxley act of
2002





In
connection with the Quarterly Report of GMS Capital Corp. (the “Company”) on
Form 10–Q for the period ended March 31, 2010, as filed with the Securities and
Exchange Commission on the date hereof (the “Report”), I, George Metrakos,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes–Oxley Act of 2002, to the best of his
knowledge, that:





1.      
The Report fully complies with the requirements of Section 13(a) or 15(d)
of the Securities Exchange Act of 1934; and





2.      
The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.





/s/
      George MetrakosGeorge
      Metrakos
              Principal
      Financial and Accounting Officer





Dated:
May 7, 2010
ex10a.htm




















Exhibit (10)(a)

















Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm












We consent to the reference to our firm under the caption “Independent Registered Public Accounting Firm” in Post-Effective Amendment No. 26 to the 1933 Act Registration Statement (Form N-4 No. 333-141757) and Amendment No. 315 to the 1940 Act Registration Statement (Form N-4 No. 811-09763), and to the use therein of our reports dated (a) April 1, 2015, with respect to the financial statements of Lincoln Life & Annuity Company of New York and (b) April 8, 2015, with respect to the financial statements of Lincoln New York Account N for Variable Annuities for the registration of interests in a separate account under individual flexible payment deferred variable annuity contracts.







/s/ Ernst & Young LLP














Philadelphia, Pennsylvania


December 23, 2015
<PAGE>

                                                                      Exhibit 23
                                                                      ----------



[KPMG LLP letterhead]



ACCOUNTANTS' CONSENT

To the Trustees of Hawaiian Electric Industries Capital Trust I:

We consent to incorporation by reference in Registration Statement Nos. 333-
18809, 333-18809-01, 333-18809-02, 333-18809-03 and 333-18809-04 on Form S-3 of
Hawaiian Electric Industries, Inc., Hawaiian Electric Industries Capital Trust
I, Hawaiian Electric Industries Capital Trust II, Hawaiian Electric Industries
Capital Trust III and HEI Preferred Funding, LP of our report dated January 23,
2001, relating to the balance sheets of Hawaiian Electric Industries Capital
Trust I as of December 31, 2000 and 1999, and the related statements of
earnings, changes in stockholders' equity and cash flows for each of the years
in the three-year period ended December 31, 2000, which report appears in this
2000 Annual Report on Form 10-K of Hawaiian Electric Industries Capital Trust I.



/s/ KPMG LLP


Honolulu Hawaii
March 26, 2001
Exhibit
10.2


  


December
31, 2015


 


Mr.
Kulendiran Purushothaman


 


Dear
Indran,


 


On
behalf of Relmada Therapeutics, Inc: (the "Company"), I am pleased to offer you the designation of Principal Financial
Officer for the Company. Your position will remain as Vice President of Finance. Speaking for myself, as well as the other members
of the management team, we are all impressed with your credentials and look forward to your future success in this position. Your
annual base salary shall be $180,000, which will be paid in accordance with the Company’s regular payroll practices. Subject
to your satisfactory performance, effective July 1, 2016, your annual base salary shall be increased to $200,000 and your target
bonus increased to 25% of your base salary. Except as set forth above, your Offer Letter with the Company dated January 21, 2015
shall remain in full force and effect.


 


IN
WITNESS WHEREOF, the parties hereto have executed this agreement as of the date first written above.


 


	RELMADA THERAPEUTICS, INC.	KULENDIRAN PURUSHOTHAMAN




  


	By:
	/s/ Sergio Traversa	 	/s/ Kulendiran Purushothaman
	 	Sergio
Traversa, CEO
<PAGE>
                                                                      Exhibit 23

              CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS

We consent to the incorporation by reference in Syntroleum Corporation's
previously filed Form S-3 Registration Statement No. 333-62290 and Form S-8
Registration Statement Nos. 333-33345, 333-53714, 333-62862 and 333-64231 of our
report related to Syntroleum Corporation dated January 24, 2003, except with
respect to the matters discussed in Note 18, as to which the date is February
10, 2003 (which expressed an unqualified opinion and included an explanatory
paragraph as to the Company's change in its disclosures of stock-based employee
compensation expense in 2002 and our audit of the transitional disclosures
related to these changes reflected in the 2001 and 2000 financial statements),
appearing in this Annual Report on Form 10-K of Syntroleum Corporation for the
year ended December 31, 2002.


                                               GRANT THORNTON LLP

Tulsa, Oklahoma
March 31, 2003